Summary of the International Consensus Symposium on advances in the diagnosis, treatment and prophylaxis of cytomegalovirus infection

Antiviral Research

Volumn 32, Issue 3, 1996, Pages 119-140

  Van Der Meer, Jan T M ^a   Drew, W Lawrence ^b,c   Bowden, Raleigh A ^d,e   Galasso, George J ^f   Griffiths, Paul D ^g   Jabs, Douglas A ^h   Katlama, Christine ⁱ   Spector, Stephen A ^j   Whitley, Richard J ^k  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f Natl Found for Biomed Research   (United States)

^g ROYAL FREE HOSPITAL   (United Kingdom)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTISENSE OLIGONUCLEOTIDE; CIDOFOVIR; CYTOMEGALOVIRUS VACCINE; FOSCARNET; GANCICLOVIR; LOBUCAVIR; SEVIRUMAB;

CENTRAL NERVOUS SYSTEM DISEASE; CONFERENCE PAPER; CYTOMEGALOVIRUS; DISEASE TRANSMISSION; DRUG RESISTANCE; GASTROINTESTINAL DISEASE; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRAVITREAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PNEUMONIA; PREGNANCY; PRIORITY JOURNAL; RETINITIS; SEROLOGY; VIRUS INFECTION;

ANIMALS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, MICROBIAL; HUMANS; INTERNATIONAL COOPERATION; VIRAL VACCINES;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030297566     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(96)01006-6     Document Type: Conference Paper

References (145)

1. Aguado, J.M., Gomez-Sanchez, M.A., Lumbreras, C. et al. (1995) Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3. Antimicrob. Agents Chemother. 39, 1643-1645.
2. Appereley, J.F. and Goldman, J.M. (1988) Cytomegalovirus: biology, clinical features and methods for diagnosis. Bone Marrow Transplant 3, 253-264.
3. Aschan, J., Ringden, O., Ljungman, P., Lonnqvist, B. and Ohlman, S. (1992) Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients. Scand. J. Infect. Dis. 24, 143-150.
4. Bailey, T.C., Trulock, E.P., Ettinger, N.A. et al. (1992) Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants. J. Infect. Dis. 165, 548-552.
5. Baldanti, F., Underwood, M.R., Stanat, S.C. et al. (1996) Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotranferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS. J. Virol. 170, 1390-1395.
6. Blanshard, C. (1992) Treatment of HIV-related cytomegalovirus disease of the gastrointestinal tract with foscarnet. J. Acquir. Immun. Defic. Syndr. 5(1), S25-S28.
7. Blanshard, C., Benhamou, Y., Dohin, E., Lernestedt, J.O., Gazzard, B.G. and Katlama, C. (1995) Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison. J. Infect. Dis. 172, 622-628.
8. Boivin, G., Chou, S., Quirk, M.R., Erice, A. and Jordan, M.C. (1996) Detection of ganciclovir resistance mutations and quantitation of cytomegalovirus (CMV) DNA in leucocytes of patients with fatal disseminated CMV disease. J. Infect. Dis. 173, 523-528.
9. Bowden, R.A. (1995) Transfusion-transmitted cytomegalovirus infection. Hemat./Onc. Clin. North Am. 9, 155-166.
10. Bowden, R.A., Fisher, L.D., Rogers, K., Cays, M. and Meyers, J.D. (1991a) Cytomegalovirus (CMV)-specific intravenous immunoglobulin for the prevention of primary CMV infection and disease after marrow transplant. J. Infect. Dis. 164, 483-487.
11. Bowden, R.A., Sayers, M.H., Cays, M. and Slichter S.J. (1989) The role of blood product filtration in the prevention of transfusion associated cytomegalovirus (CMV) infection after marrow transplant [abstract]. Transfusion 29(Suppl), 57S.
12. Bowden, R.A., Sayers, M., Flournoy, N. et al. (1986) Cytomegalovirus immuneglobulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. New Engl. J. Med. 314, 1006-1010.
13. Bowden, R.A., Slichter, S.J., Sayers, J.H., Mori, M., Cays, M.J. and Meyers, J.D. (1991b) Use of leucocyte-depleted platelets and cytomegalovirus-negative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood 78, 246-250.
14. Bowen, E.F., Wilson, P., Atkins, M. et al. (1996) Natural history of untreated cytomegalovirus retinitis. Lancet 346, 1671-1673.
15. Britt, W.J. (1991) Recent advances in the identification of significant human cytomegalovirus-encoded proteins. Transplant. Proc. 23(3), 64-69.
16. Britt, W.J. and Alford, C.A. (1996) Cytomegalovirus. In: B.N Fields, D.M. Knipe, P.M. Howley, et al., (Eds.), Fields Virology, 3rd edn, ch. 77. Lippincott-Raven, Philadelphia, 1996.
17. Brown, J.M., Kaneshima, H. and Mocarski, E.S. (1995) Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J. Infect. Dis. 171, 1599-1603.
18. Bylsma, S.S., Achim, C.L., Wiley, C.A. et al. (1995) The predictive value of cytomegalovirus retinitis for cytomegalovirus encephalitis in acquired immunodeficiency syndrome. Arch. Ophthalmol. 113, 89-95.
19. Cha, T.A., Tom, E., Kemble, G.W., Duke, G.M., Mocarski, E.S. and Spaete, R.R. (1996) Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70, 78-83.
20. Chachoua, A., Dieterich, D., Krasinski, K. et al. (1987) 9-(1,3-Dihydroxy-2-propoxymethyl)guanine (ganciclovir) in the treatment of cytomegalovirus gastrointestinal disease with the acquired immunodeficiency syndrome. Ann. Intern. Med. 107, 133-137.
21. Chee, M.S., Bankier, A.T., Beck, S. et al. (1990) Analysis of the protein coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154, 125-169.
22. Cinque, P., Vago, L., Brytting, M. et al. (1992) Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid. J. Infect. Dis. 166, 1408-1411.
23. Collier, A.C., Meyers, J.D., Corey, L. et al. (1987) Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunity. Am. J. Med. 23, 593-601.
24. Conti, D.J., Freed, B.M., Gruber, S.A. and Lempert, N. (1994) Prophylaxis of primary cytomegalovirus disease in renal transplant recipients. A trial of ganciclovir vs immunoglobulin. Arch. Surgery 129, 443-447.
25. Curtsinger, J.M., Liu, Y.N., Radeke, R. et al. (1994) Molecular analysis of the immune response to human cytomegalovirus glycoprotein B (gB). II. Low gB-specific T and B cell responses are associated with expression of certain HLA-DR alleles. J. Gen. Virol. 75, 301-307.
26. Diaz-Llopis, M., Chipont, E., Sanchez, S., Espana, E., Navea, A. and Menezo, J.L. (1992) Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome. Am. J. Ophthalmol. 114, 742-747.
27. Diaz-Llopis, M., Espana, E., Munoz, G. et al. (1994) High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS. Br. J. Ophthalmol. 78, 120-124.
28. Dieterich, D.T., Chachoua, A., Lafleur, F. and Worrell, C. (1988) Ganciclovir treatment of gastrointestinal infections caused by cytomegalovirus in patients with AIDS. Rev. Infect. Dis. 10(3), S532-537.
29. Dieterich, D.T., Kotler, D.P., Busch, D.F. et al. (1993a) Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study. J. Infect. Dis. 167, 278-282.
30. Dieterich, D.T., Poles, M.A., Dicker, M., Tepper, R. and Lew, E. (1993b) Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction. Am. J. Gastroenterology 88, 542-548.
31. Dieterich, D.T., Poles, M.A., Lew, E.A. et al. (1992) Concurrent use of ganciclovir and foscarnet in treatment of cytomegalovirus infection in AIDS. J. Infect. Dis. 167, 1184-1188.
32. Dowling, J.N., Wu, B.C., Ho, M. et al. (1977) Enhancement of murine cytomegalovirus infection during graft versus host reaction. J. Infect. Dis. 135, 990-994.
33. Drew, W.L., Ives, D., Lalezari, J.P. et al. (1995) Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group. New Engl. J. Med. 333, 615-620.
34. Drew, W.L., Mintz, L., Miner, R.C., Sands, M. and Ketterer, B. (1981) Prevalence of cytomegalovirus in homosexual men. J. Infect. Dis. 143, 188-192.
35. Drew, W.L., Sweet, E.S., Miner, R.C. et al. (1984) Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization. J. Infect. Dis. 150, 952-953.
36. Einsele, H., Ehninger, G., Hebart, H. et al. (1995) Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 86, 2815-2820.
37. Emanuel, D., Cunningham, I., Jules-Elysee, K. et al. (1988) Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann. Intern. Med. 109, 777-782.
38. Engstrom, R.E. Jr. and Holland, G.N. (1995) Local therapy for cytomegalovirus retinopathy. Am. J. Ophtalmol. 120, 376-385.
39. Enting, R., de Gans, J., Reiss, P., Jansen, C. and Portegies, P. (1992) Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS [letter]. Lancet 340, 559-560.
40. Fowler, K.B., Stagno, S., Pass, R.F., Britt, W.J., Boll, T.J. and Alford, C.A. (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. New. Engl. J. Med. 326, 663-667.
41. Fox, J.C., Kidd, I.M., Griffiths, P.D., Sweny, P. and Emery, V.C. (1995) Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J. Gen. Virol. 76, 309-319.
42. Freitas, V.R., Fraser-Smith, E.B. and Matthews, T.R. (1989) Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus 2 in vitro and in vivo. Antiviral. Res. 12, 205-212.
43. Goodgame, R.W. (1993) Gastrointestinal cytomegalovirus disease. Ann. Intern. Med. 119, 924-935.
44. Goodrich, J.M., Bowden, R.A., Fisher, L., Keller, C., Schoch, G. and Meyers, J.D. (1993) Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann. Intern. Med. 118, 173-178.
45. Grefte, A., van der Giessen, M., Harmsen, M.C., van Son, W.J. and The, T.H. (1996) In vitro generation of human cytomegalovirus lower matrix protein pp65 positive polymorphonuclear leucocytes. In: A. Grefte, Dissemination of Human Cytomegalovirus. Role of Leucocytes and Endothelial Cells. Thesis, Groningen.
46. Griffiths, P.D., Panjwani, D.D., Stirk, P.R. et al. (1984) Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci. Lancet 2, 1242-1245.
47. Grundy, J.E., Lui, S.F., Super, M. et al. (1988) Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet 2, 132-135.
48. Grundy, J.E., Shanley, J.D. and Griffiths, P.D. (1987) Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet 2, 996-999.
49. Hall, A.J., Jennens, I.D., Lucas, C.R., MacLean, H. and Sandland, A.M. (1991) Low frequency maintenance ganciclovir for cytomegalovirus retinitis. Scand. J. Infect. Dis. 23, 43-46.
50. Handsfield, H.H., Chandler, S.H., Caine, V.A. et al. (1985) Cytomegalovirus infection in sex partners. Evidence for sexual transmission. J. Infect. Dis. 151, 344-348.
51. Henry, K., Cantrill, H., Fletcher, C., Chinnock, B.J. and Balfour, H.H. Jr. (1987) Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am. J. Ophtalmol. 103, 17-23.
52. Ho, M. (1977) Virus infections after transplantation in man. Arch. Virol. 55, 1-24.
53. Ho, M. Cytomegalovirus: Biology and Infection, 2nd edn, Plenum, New York, 1991.
54. Ho, M., Suwansirikul, S., Dowling, J.N., et al. (1975) The transplanted kidney as a source of cytomegalovirus infection. New Engl. J. Med. 293, 1109-1112.
55. Horwitz, C.A., Henle, W., Henle, G., et al. (1986) Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine 65, 124-134.
56. Jacobson, M.A., Causey, D., Polsky, B. et al. (1993) A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS. J. Infect. Dis. 168, 444-448.
57. Jacobson, M.A., Kramer, F., Bassiakos, Y. et al. (1994) Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS Clinical Trials Group Protocol 151. J. Infect. Dis. 170, 189-193.
58. Jacobson, M.A., Mills, J., Rush, J. et al. (1988a) Failure of antiviral therapy for acquired immunodeficiency syndrome - related cytomegalovirus myelitis. Arch. Neurol. 45, 1090-1092.
59. Jacobson, M.A., O'Donnell, J.J., Brodie, H.R., Wofsy, C. and Mills, J. (1988b) Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis. J. Med. Virol. 25, 339-349.
60. Jacobson, M.A., O'Donnell, J.J., Porteous, D., Brodie, H.R., Feigal, D. and Mills, J. (1988) Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immune deficiency syndrome: prevalence, natural history, and response to ganciclovir therapy. Q. J. Med. 67, 473-486.
61. Johnson, M.R., Mullen, G.M., O'Sullivan, E.J. et al. (1994) Risk/benefit ratio of perioperative OKT3 in cardiac transplantation. Am. J. Cardiol. 74, 261-266.
62. Kaplan, C.S., Petersen, E.A., Icenogle, T.B. et al. (1989) Gastrointestinal cytomegalovirus infection in heart and heart-lung transplant recipients. Arch. Intern. Med. 149, 2095-2100.
63. Kari, B., Lussenhop, N., Goertz, R. et al. (1986) Characterization of monoclonal antibodies reaction to several biochemically distinct human cytomegalovirus glycoprotein complexes. J. Virol. 60, 345-352.
64. Katlama, D., Dohin, E., Caumes, E. et al. (1992) Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens. J. Acquir. Immun. Defic. Syndr. 5(1), S18-24.
65. Kern, E.R. (1991) The value of animal models to evaluate agents with potential activity against human cytomegalovirus. Transplant Proc. 23, 152-155.
66. Kirsch, L.S., Arevalo, J.F., Chavez, de la Paz E., Munguia, D., De Clercq, E. and Freeman, W.R. (1995) Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmol. 102, 533-542.
67. Knox, K.K., Drobyski, W.R. and Carrigan, D.R. (1991) Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient. Lancet 2, 1292-1293.
68. Krech, U. Complement-fixing antibodies against cytomegalovirus in different parts of the world. Bull. WHO 49, 103-106.
69. Laguna, F., Garcia-Samaniego, J., Alonso, M.J., Alvarez, I. and Gonzalez-Lahoz, J.M. (1993) Pseudotumoral appearance of cytomegalovirus esophagitis and gastritis in AIDS patients. Am. J. Gastroent. 88, 1108-1111.
70. Lee, J.Y., Irmiere, A. and Gibson, W. (1988) Primate cytomegalovirus assembly: evidence that DNA packaging occurs subsequent to B capsid assembly. J. Virol. 167, 87-96.
71. Ljungman, P., de Bock, R., Cordonnier, C. et al. (1993) Practice for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the working party for infectious diseases of the EBMT. Bone Marrow Transpl. 12, 399-403.
72. Marshall, G.S., Ricciardi, R.P., Rando, R.F. et al. (1990) An adenovirus recombinant that expresses the human cytomegalovirus major envelope glycoprotein and induces neutralizing antibodies. J. Infect. Dis. 162, 1177-1181.
73. Martin, W.J. and Smith, T.F. (1986) Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens by a monoclonal antibody method. J. Clin. Microbiol. 23, 1006-1008.
74. Martin, M. (1994) Combination antiviral strategies in managing cytomegalovirus infection. Transplant. Proc. 26, 28-30.
75. Martin, D.E., Parks, D.J., Mellow, S.D. et al. (1994) Treatment of cytomegalovirus retinitis with an intraocular sustained-releaseganciclovir implant. Arch. Ophtalmol. 112, 1531-1539.
76. Mayoral, J.L., Loeffler, C.M., Fasola, C.G. et al. (1991) Diagnosis and treatment of cytomegalovirus disease in transplant patients based on gastrointestinal tract manifestations. Arch. Surg. 126, 202-206.
77. McCarthy, A.L., Malik Peiris, J.S., Taylor, C.E. et al. (1992) Increase in severity of graft versus host disease by cytomegalovirus. J. Clin. Pathol. 45, 542-544.
78. McLaughlin-Taylor, E., Pande, H., Forman, S.J. et al. (1994) Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CDS + virus-specific cytotoxic T lymphocytes. J. Med. Vir. 43, 103-110.
79. Merigan, T.C., Reylund, D.G., Keay, S. et al. (1992) A controlled trial to prevent cytomegalovirus disease after heart transplantation. New Engl. J. Med. 326, 1182-1186.
80. Messori, A., Rampazzo, R., Scroccaro, G. and Martini N. (1994) Efficacy of hyperimmune anti-cytomegalovirus immunoglobulins for the prevention of cytomegalovirus infection in recipients of allogeneic bone marrow transplantation: a meta-analysis. Bone Marrow Transplant 13, 163-167.
81. Meyers, J.D., Flournoy, N. and Thomas, E.D. (1986) Risk factors for cytomegalovirus infections after human marrow transplant. J. Infect. Dis. 153, 478-488.
82. Millar, A.B., Patou, G., Miller, R.F. et al. (1990) Cytomegalovirus in the lungs of patients with AIDS: respiratory pathogen or pathogen? Am. Rev. Resp. Dis. 141, 1474-1477.
83. Miller, W.J., McCullough, J., Balfour, H.H. Jr. et al. (1991) Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening. Bone Marrow Transplant 7, 227-234.
84. Mocarski, E.S., Bonyhadi, M., Salimi, S., McCune, J.M.F. and Kaneshima, H. (1993) Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication. Proc. Natl. Acad. Sci. USA 90, 104-108.
85. Mocarski, E.S.J. (1993) Cytomegalovirus biology and replication. In: B. Roizman, R.J. Whitley and C. Lopez (Eds.) The Human Herpesviruses, pp. 173-226, Raven Press, New York, 1993.
86. Moulignier, A., Mikol, J., Gonzalez-Canali, G. et al. (1996) AIDS-associated cytomegalovirus infection mimicking central nervous system tumors: a diagnostic challenge. Clin. Infect. Dis. 22, 626-631.
87. Palestine, A.G., Polis, M.A., De Smet, M.D. et al. (1991) A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann. Intern. Med. 115, 665-673.
88. Pan, G.S., Field, A.K. and Smith, J.A. (1995) Potent antiviral activity of an antisense oligonucleotide complementary to the intron-exon boundary of human cytomegalovirus genes UL36 and UL37. Antimicrob. Agents Chemother. 39, 1157-1161.
89. Patel, R., Klein, D.W., Espy, M.J. et al. (1995a) Optimization of detection of cytomegalovirus viremia in transplantation recipients by shell vial assay. J. Clin. Microbiol. 33, 2980-2986.
90. Patel, R., Smith, T.F., Espy, M. et al. (1995b) A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J. Infect. Dis. 171, 1010-1014.
91. Paya, C.V., Wold, A.D., Ilstrup, D.M. and Smith, T.F. (1988) Evaluation of number of shell vial cell cultures per clinical specimen for rapid diagnosis of cytomegalovirus infection. J. Clin. Microbiol. 26, 198-200.
92. Peters, M., Timm, U., Schurmann, D., Pohle, H.D. and Ruf, B. (1992) Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature. Clin. Invest. 70, 456-458.
93. Plotkin, S.A. (1994) Vaccines for varicella-zoster virus and cytomegalovirus: recent progress. Science 265, 1383-1385.
94. Pollard, R.B. (1996) CMV retinitis: ganciclovir/monoclonal antibody. Antiviral. Res. 29, 73-75.
95. Portela, D., Patel, R., Larson-Keller, J.J. et al. (1995) OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation. J. Infect. Dis. 171, 1014-1018.
96. Pouteil-Noble, C., Ecochard, R., Landrivon, G. et al. (1993) Cytomegalovirus infection - an etiological factor for rejection? Transplantation 55, 851-857.
97. Rasmussen, L. (1990) Immune response to human cytomegalovirus infection. Curr. Top. Microbiol. Immunol. 154, 221-254.
98. Rasmussen, L., Matkin, C., Spaete, R., Pachl, C. and Merigan, T.C. (1991) Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans. J. Infect. Dis. 164, 835-842.
99. Rasmussen, L., Nelson, M., Neff, M. and Merigan, T.C. Jr. (1988) Characterization of two different human cytomegalovirus glycoproteins which are targets for virus neutralizing antibody. Virology 163, 308-318.
100. Raynor, B.D. (1993) Cytomegalovirus infection in pregnancy. Semin. Perinatology 17, 394-402.
101. Reed, B.C., Bowden. R.A., Dandliker, P.S., Gleaves, C.A. and Meyers, J.D. (1987) Efficacy of cytomegalovirus immunoglobuhn in marrow transplant recipients with cytomegalovirus pneumonia. J. Infect. Dis. 156, 41-645.
102. Reed, E.C., Bowden, R.A., Dandliker, P.S., Lilleby, K.E. and Meyers, J.D. (1988a) Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann. Intern. Med. 109, 783-788.
103. Reed, E.C., Shepp, D.H., Dandliker, P.S. and Meyers. J.D. (1988b) Ganciclovir treatment of cytomegalovirus infection of the gastrointestinal tract after marrow transplantation. Bone Marrow Transpl. 3, 199-206.
104. Reed, E.C., Dandliker, P.S. and Meyers, J.D. (1986) Treatment of cytomegalovirus pneumonia with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine and high-dose corticosteroids. Ann. Intern. Med. 105, 214-215.
105. Reusser, P., Riddell, S.R., Meyers, J.D., and Greenberg, P.D. (1991) Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78, 1373-1380.
106. Rubin, R.H. (1994) Infection in organ transplant recipients. In: R.H. Rubin and L.S. Young (Eds.), Clinical approach to infection in the compromised host, 3rd edn, Plenum, New York, 1994.
107. Rubin, R.H. and Tolkoff-Rubin, N.E. (1993) Antimicrobial strategies in the care of organ transplant recipients. Antimicrob. Agents Chemother. 37, 619-624.
108. Rich, J.D., Crawford, J.M., Kazanjian, S.N. and Kazanjian, P.H. (1992) Discrete gastrointestinal mass lesions caused by cytomegalovirus in patients with AIDS: report of three cases and review. Clin. Infect. Dis. 15, 609-614.
109. Sarasini, A.F., Baldanti, M., Furione, E. et al. (1995) Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients. J. Med. Virol. 47, 237-244.
110. Sawyer, M.H., Edwards, D.K. and Spector, S.A. (1987) Cytomegalovirus infection and bronchopulmonary dysplasia in premature infants. Am. J. Dis. Child 141, 303-305.
111. Schmidt, C.A., Oettle, H., Wilborn, F. et al. (1994) Demonstration of cytomegalovirus after bone marrow transplantation by polymerase chain reaction, virus culture and antigen detection in buffy coat leukocytes. Bone Marrow Transplant 13, 71-75.
112. Schrier, R.D., Freeman, W.R., Wiley, C.A., McCutchan, J.A. and the HNRC group. (1995) Immune predispositions for cytomegalovirus retinitis in AIDS. J. Clin. Invest. 95, 1741-1746.
113. Shepp, D.H., Dandliker, P.S., de Miranda, P. et al. (1985) Activity of 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine in the treatment of cytomegalovirus pneumonia. Ann. Intern. Med. 103, 368-373.
114. Singh, N., Dummer, J.S., Kusne, S., et al. (1988) Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J. Infect. Dis. 158, 124-131.
115. Smiley, M.L., Wlodaver, C.G., Grossman, R.A. et al. (1985) The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation. Transplantation 40, 157-161.
116. Smith, K.L. and Dunstan. R.A. (1993) PCR detection of cytomegalovirus: a review. Br. J. Haematol. 84, 187-190.
117. Smith, T.F. and Shelley, C.D. (1988) Detection of IgM antibody to cytomegalovirus and rapid diagnosis of this virus infection by the shell vial assay. J. Virol. Methods 21, 87-96.
118. Spaete, R.R., Gehrz, R.C. and Landini, M.P. (1994) Human cytomegalovirus structural proteins. J. Gen. Virol. 75, 3287-3308.
119. Spector, S.A., Hirata, K.K. and Newman, T.R. (1984) Identification of multiple cytomegalovirus strains in homosexual men with acquired immunodeficiency syndrome. J. Infect. Dis. 150, 953-956.
120. Spector, S.A., McKinley, G.F., Lalezari, J.P. et al. (1996) For the Roche Cooperative Oral Ganciclovir Study Group: Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. New. Engl. J. Med. 334, 1491-1497.
121. Spector, S.A., Merrill, R., Wolf, D. and Dankner, W.M. (1992) Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J. Clin. Microbiol. 30, 2359-2365.
122. Spector, S.A., Weingeist, T., Pollard, R.B. et al. (1993) A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group. J. Infect. Dis. 168, 557-563.
123. Stagno, S. and Cloud, G.A. (1994) Working parents: the impact of day care and breast-feeding on cytomegalovirus infections in offspring. Proc. Natl. Acad. Sci. USA 91, 2384-2389.
124. Stagno, S., Reynolds, D.W., Amos, C.S. et al. (1977) Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegalovirus and toxoplasma infection. Pediatrics 59, 669-678.
125. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. (1992) Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. New Engl. J. Med. 326, 213-220.
126. Studies of Ocular Complications of AIDS Research Group, in collaboration the AIDS Clinical Trials Group. (1994) The foscarnet-ganciclovir cytomegalovirus retinitis trial: 4. Visual outcomes. Ophthalmology 101, 1250-1261.
127. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. (1995) Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Arch. Intern. Med. 155, 65-74.
128. Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. (1996) Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. Arch. Ophthalmology 114, 23-33.
129. Sullivan, K.M., Kopecky, K.J., Jocom, J. et al. (1990) Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. New. Engl. J. Med. 323, 705-712.
130. Tanaka, K., Koga, Y., Lu, Y.Y. et al. (1994) Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus. J. Clin. Invest. 94, 1019-1025.
131. The Oral Ganciclovir European and Australian Cooperative Study Group. (1995) Intravenous versus oral ganciclovir: European/Australian comparitive study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. AIDS 9, 471-477.
132. Van der Bij, W., Torensma, R., van Son, W.J. et al. (1988) Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J. Med. Virol. 25, 179-188.
133. Verdonck, L.F., de Gast, G.C., Dekker. A.W., de Weger, R.A., Schuurman, H.J. and Rozenberg-Arska, M. (1989) Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir. Bone Marrow Transplant 4, 187-189.
134. Walter, E.A., Greenberg, P.D., Gilbert M.J. et al. (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New Engl. J. Med. 333, 1038-1044.
135. Weber, J.N., Thom, S., Barrison, I., et al. (1987) Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS: clinical manifestations and preliminary report of treatment with foscarnet (phosphonoformate). Gut 28, 482-487.
136. Wertheim, P., Buurman, C., Geelen, J. and van der Noordaa, J. (1983) Transmission of cytomegalovirus by renal allograft demonstrated by restriction enzyme analysis [letter]. Lancet 1, 980-981.
137. Wilcox, C.M., Straub, R.F. and Schwarte D.A. (1995) Cytomegalovirus esophagitis in AIDS: a prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome. Am. J. Med. 98, 169-176.
138. Wingard, J.R., Chen, D.Y., Burns, W.H. et al. (1988) Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood 71, 1432-1437.
139. Winston, D.J., Ho, W.G., Bartoni, K. et al. (1993) Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial. Ann. Intern. Med. 118, 179-184.
140. Winston, D.J., Ho, W.G. and Champlin, R.E. (1990) Cytomegalovirus infection after allogenic bone marrow transplantation. Rev. Infect. Dis. 12(Suppl 7), 5776-5792.
141. Winston, D.J., Wirin, D., Shaked, A. and Busuttil, R.W. (1995) Randomised comparison of ganciclovir and high-dose acyclovir for long-term prophylaxis in liver-transplant recipients. Lancet 346, 69-74.
142. Wolf, D.G. and Spector, S.A. (1992) Diagnosis of human cytomegalovirus central nervous system disease in AIDS patients by DNA amplification from cerebrospinal fluid. J. Infect. Dis. 166, 1412-1415.
143. Wolf, D. and Spector, S.A. (1993) Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma. Transplantation 56, 330-334.
144. Wu, B.C., Dowling, J.N., Ho, M., et al. (1975) Enhancement of mouse cytomegalovirus infection during host versus graft reaction. Science 190, 56-58.
145. Zaia, J. A. (1993) Prevention and treatment of cytomegalovirus pneumonia in transplant recipients. Clin. Infect. Dis. 17(Suppl 2), S392-399.